Stop parsing PDFs. Get the API. Request Access
Benitec Biopharma Inc. Logo

Benitec Biopharma Inc.

A clinical-stage biotech developing genetic medicines to silence disease-causing genes.

BNTC | US

Overview

Corporate Details

ISIN(s):
US08205P2092
LEI:
Country:
United States of America
Address:
3940 TRUST WAY, 94545 HAYWARD
Website:
https://benitec.com/
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development of novel genetic medicines. The company utilizes its proprietary DNA-Directed RNA Interference (ddRNAi) platform, which combines gene therapy with RNA interference (gene silencing) to create treatments. This technology is designed to permanently silence disease-causing genes. Benitec's therapeutic programs target chronic and life-threatening human diseases that are gene-associated and for which there are currently no effective treatments or cures.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Benitec Biopharma Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Benitec Biopharma Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Benitec Biopharma Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aprogen, Inc Logo
Aprogen, Inc
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Aquestive Therapeutics, Inc.
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Arbutus Biopharma Corp
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
Arcellx, Inc.
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Arctic Bioscience
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
ArcticZymes Technologies
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.